Stapgen
Early Stage
We aim to prevent T2DM prior to the rise of blood sugar.
Overview
Raised: $0
Total Commitments ($USD)
Platform
Wefunder
Start Date
11/15/2022
Close Date
12/17/2022
Min. Goal
$50,000
Max. Goal
$85,000
Min. Investment
$100
Security Type
SAFE
Series
Seed
SEC Filing Type
RegCF
Valuation Cap
$20,000,000
Discount
0%
Rolling Commitments ($USD)
Status
Not Funded
Reporting Date
12/18/2022
Days Remaining
Not Funded
% of Min. Goal
0%
% of Max. Goal
0%
Likelihood of Max
Not Funded
Avg. Daily Raise
$0
Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2022
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Stapgen, with a valuation of $20 million, is raising funds on Wefunder. The company has developed its patented STAP-Test, used as the preventive test for Type 2 diabetes. The test will be used to detect the risk of Type 2 diabetes in advance, even before the rise of blood sugar, so that the disease can be intercepted. Stapgen is led by an experienced team and has granted a patent for the US with patents pending in other countries. Biplab K. Malo founded Stapgen in February 2022. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $85,000. The campaign proceeds will be used for product development, lab rental, and product promotion.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$0 |
$0 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$0 |
$0 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$0 |
$0 |
|
Short-Term Debt |
$0 |
$0 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$0 |
$0 |
Financials as of: 11/15/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Are you the founder of Stapgen? Create your account today to claim this raise page.